Intended for healthcare professionals


Medicare slashes payment for BRCA test

BMJ 2013; 347 doi: (Published 31 December 2013) Cite this as: BMJ 2013;347:f7709
  1. Michael McCarthy
  1. 1Seattle

Medicare, the US health insurance plan for elderly and disabled people, will halve its maximum reimbursement for the BRCA1 and BRCA2 breast cancer gene tests to $1440, down from the maximum of $2795 it paid in 2013, the US Centers for Medicare and Medicaid Services …

View Full Text

Log in

Log in through your institution


* For online subscription